Drug Delivery through Blood-Brain Barrier

The brain is shielded and segregated from the normal circulation by a highly adequate blood-brain barrier. This is characterised by relatively impermeable endothelial cells with tight junctions, enzymatic activity and active efflux transport systems. Therefore the blood-brain barrier is layout to allow discriminatory carrier of molecules that are important for brain function. This builds a extensive protest for the treatment of central nervous system diseases compelling therapeutic levels of drug to get into the brain. Some small lipophilic drugs diffuse across the blood-brain barrier- sufficiently well to be efficacious. However, many potentially useful drugs are excluded.

 

  • Permeable Blood-Brain Barrier
  • Actively Targeted Delivery
  • Non-Invasive Techniques
  • Nanoparticles for Brain Imaging/Diagnostics

Related Conference of Drug Delivery through Blood-Brain Barrier

April 04-05, 2024

17th European Biosimilars Congress

Madrid, Spain
April 11-12, 2024

5th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
May 09-10, 2024

4th Global Summit on Pharmaceutical Research

Barcelona, Spain
May 16-17, 2024

18th World Drug Delivery Summit

Rome, Italy
May 30-31, 2024

9th Pharmaceutical Chemistry Conference

Paris, France
July 25-26, 2024

34th Annual European Pharma Congress

Zurich, Switzerland
September 11-12, 2024

9th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
December 05-06, 2024

17th World Drug Delivery Summit

Dubai, UAE

Drug Delivery through Blood-Brain Barrier Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in